MSA (3 mg/kg body weight) inhibited tumor growth by up to 61% compared with the control group, which was associated with a decrease in the levels of tumor necrosis factor TNFα and interleukin 6 (IL6) [55]. The gene discussed is IL6; the disease is neoplasm.